Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Epizyme Inc (NQ: EPZM ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 11, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.460 (51) Ask (Size) 1.470 (263) Prev. Close 1.470 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 168,364,752 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Epizyme: Q2 Earnings Insights August 09, 2022 Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update August 09, 2022 From Epizyme, Inc. Via Business Wire Performance More News Read More EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM July 12, 2022 From Kahn Swick & Foti, LLC Via Business Wire EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM June 27, 2022 From Kahn Swick & Foti, LLC Via Business Wire Why Is Epizyme (EPZM) Stock Up 75% Today? June 27, 2022 Via InvestorPlace Why Epizyme Shares Are Soaring Today June 27, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 June 28, 2022 Via Benzinga The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies June 27, 2022 Via Benzinga Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027 June 28, 2022 Via FinancialNewsMedia Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal June 27, 2022 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022 June 27, 2022 Via Benzinga This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday June 28, 2022 Via Benzinga Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session June 27, 2022 Via Benzinga EPZM Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Epizyme, Inc. Is Fair to Shareholders June 27, 2022 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session June 27, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 27, 2022 Via InvestorPlace Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why June 27, 2022 Via Benzinga Epizyme + 20 Stocks Moving In Monday's Pre-Market Session June 27, 2022 Via Benzinga Ipsen to acquire Epizyme, expanding its portfolio in oncology June 27, 2022 From Epizyme, Inc. Via Business Wire 76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More June 23, 2022 Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session June 22, 2022 Via Benzinga 20 Stocks Moving in Tuesday's Pre-Market Session June 14, 2022 Via Benzinga 93 Biggest Movers From Yesterday June 14, 2022 Via Benzinga 91 Biggest Movers From Friday June 13, 2022 Via Benzinga 44 Stocks Moving In Friday's Mid-Day Session June 10, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
